MDNA11 drug page Clinical trials

Trials with MDNA11

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
7Countries
115Planned patients

Showing 1–1 of 1

A Beta-only IL-2 ImmunoTherapY Study
Ongoing, not recruiting Phase 1 115 patients NCT05086692

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibi…

United States, Australia, Canada, Ireland and 3 more Aug 2021 – Dec 2026 Interventional
Combined with: Pembrolizumab